Changing climate and socioeconomic factors contribute to global antimicrobial resistance

IF 58.7 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Weibin Li, Tingting Huang, Chaojie Liu, Haishaerjiang Wushouer, Xinyi Yang, Ruonan Wang, Haohai Xia, Xiying Li, Shengyue Qiu, Shanquan Chen, Hung Chak Ho, Cunrui Huang, Luwen Shi, Xiaodong Guan, Guobao Tian, Gordon Liu, Kristie L. Ebi, Lianping Yang
{"title":"Changing climate and socioeconomic factors contribute to global antimicrobial resistance","authors":"Weibin Li, Tingting Huang, Chaojie Liu, Haishaerjiang Wushouer, Xinyi Yang, Ruonan Wang, Haohai Xia, Xiying Li, Shengyue Qiu, Shanquan Chen, Hung Chak Ho, Cunrui Huang, Luwen Shi, Xiaodong Guan, Guobao Tian, Gordon Liu, Kristie L. Ebi, Lianping Yang","doi":"10.1038/s41591-025-03629-3","DOIUrl":null,"url":null,"abstract":"<p>Climate change poses substantial challenges in containing antimicrobial resistance (AMR) from a One Health perspective. Using 4,502 AMR surveillance records involving 32 million tested isolates from 101 countries (1999–2022), we analyzed the impact of socioeconomic and environmental factors on AMR. We also established forecast models based on several scenarios, considering antimicrobial consumption reduction, sustainable development initiatives and different shared socioeconomic pathways under climate change. Our findings reveal growing AMR disparities between high-income countries and low- and middle-income countries under different shared socioeconomic pathway scenarios. By 2050, compared with the baseline, sustainable development efforts showed the most prominent effect by reducing AMR prevalence by 5.1% (95% confidence interval (CI): 0.0–26.6%), surpassing the effect of antimicrobial consumption reduction. Key contributors include reducing out-of-pocket health expenses (3.6% (95% CI: −0.5 to 21.4%)); comprehensive immunization coverage (1.2% (95% CI: −0.1% to 8.2%)); adequate health investments (0.2% (95% CI: 0.0–2.4%)) and universal access to water, sanitation and hygiene services (0.1% (95% CI: 0.0–0.4%)). These findings highlight the importance of sustainable development strategies as the most effective approach to help low- and middle-income countries address the dual challenges of climate change and AMR.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"24 1","pages":""},"PeriodicalIF":58.7000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03629-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Climate change poses substantial challenges in containing antimicrobial resistance (AMR) from a One Health perspective. Using 4,502 AMR surveillance records involving 32 million tested isolates from 101 countries (1999–2022), we analyzed the impact of socioeconomic and environmental factors on AMR. We also established forecast models based on several scenarios, considering antimicrobial consumption reduction, sustainable development initiatives and different shared socioeconomic pathways under climate change. Our findings reveal growing AMR disparities between high-income countries and low- and middle-income countries under different shared socioeconomic pathway scenarios. By 2050, compared with the baseline, sustainable development efforts showed the most prominent effect by reducing AMR prevalence by 5.1% (95% confidence interval (CI): 0.0–26.6%), surpassing the effect of antimicrobial consumption reduction. Key contributors include reducing out-of-pocket health expenses (3.6% (95% CI: −0.5 to 21.4%)); comprehensive immunization coverage (1.2% (95% CI: −0.1% to 8.2%)); adequate health investments (0.2% (95% CI: 0.0–2.4%)) and universal access to water, sanitation and hygiene services (0.1% (95% CI: 0.0–0.4%)). These findings highlight the importance of sustainable development strategies as the most effective approach to help low- and middle-income countries address the dual challenges of climate change and AMR.

Abstract Image

气候变化和社会经济因素促进了全球抗菌素耐药性
从同一个健康的角度来看,气候变化对遏制抗菌素耐药性(AMR)构成了重大挑战。利用1999-2022年来自101个国家的4502份AMR监测记录(涉及3200万株检测分离株),分析了社会经济和环境因素对AMR的影响。我们还建立了基于几种情景的预测模型,考虑了气候变化下抗菌素消费减少、可持续发展倡议和不同的共享社会经济路径。我们的研究结果表明,在不同的共享社会经济路径情景下,高收入国家与低收入和中等收入国家之间的抗菌素耐药性差距正在扩大。到2050年,与基线相比,可持续发展努力的效果最为显著,将AMR患病率降低了5.1%(95%可信区间(CI): 0.0-26.6%),超过了减少抗微生物药物消费的效果。主要贡献因素包括减少自付医疗费用(3.6%(95%置信区间:- 0.5至21.4%));综合免疫覆盖率(1.2% (95% CI: - 0.1%至8.2%));充足的卫生投资(0.2%(95%置信区间:0.0-2.4%))和普遍获得水、环境卫生和个人卫生服务(0.1%(95%置信区间:0.0-0.4%))。这些发现突出了可持续发展战略的重要性,可持续发展战略是帮助低收入和中等收入国家应对气候变化和抗生素耐药性双重挑战的最有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature Medicine
Nature Medicine 医学-生化与分子生物学
CiteScore
100.90
自引率
0.70%
发文量
525
审稿时长
1 months
期刊介绍: Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信